A Traceable Cancer Model: DNA Damage, Fragile Site-SMGs, Mitotic Slippage, 4n-Genome-Reduction to Fitness-Gained, Initiating, 2n First Cells

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.net/journal/jct
E-mail: [email protected]

Citations

"A Traceable Cancer Model: DNA Damage, Fragile Site-SMGs, Mitotic Slippage, 4n-Genome-Reduction to Fitness-Gained, Initiating, 2n First Cells"
written by Kirsten H. Walen,
published by Journal of Cancer Therapy, Vol.12 No.6, 2021

has been cited by the following article(s):

[1]	Epigenetic Enabled Normal Human Cells, Lead to First Cell's Unique Division System, Driving Tumorigenesis Evolution
	Journal of Cancer Therapy, 2022

Top

[1]	Amitotic Cell Division, Malignancy, and Resistance to Anticancer Agents: A Tribute to Drs. Walen and Rajaraman Cancers, 2024 DOI:10.3390/cancers16173106

[2]	Epigenetic Enabled Normal Human Cells, Lead to First Cell’s Unique Division System, Driving Tumorigenesis Evolution Journal of Cancer Therapy, 2022 DOI:10.4236/jct.2022.131004